Safety and dosing study for a new sepsis-related blood clotting treatment
Part of Blood & lymphatic, Heart & circulation, Infections clinical trials.
This study tests a new drug (BAY 3389934) for people with sepsis who also have a blood clotting problem. It aims to find the right dose and make sure the drug is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have sepsis, a serious infection that affects your organs.
- You have a blood clotting issue linked to your sepsis (like low platelets or abnormal clotting tests).
- You are being treated in an intensive care unit (ICU).
- You do not have active bleeding or a bleeding disorder.
- You are not taking blood thinners or certain other medications at full doses.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how often sepsis leads to blood clotting issues in critically ill patients, and what happens to those patients. It aims to help doctors better understand and treat this complication.
This study is testing a new blood test that looks at how well your blood clots to see if it can help find sepsis (a severe response to infection) earlier. It is for adults who might have an infection, but you cannot be taking certain medications or have certain health conditions.
This trial tests if the drug Sivelestat can help people in the intensive care unit who have septic shock and a specific type of blood clotting problem. It aims to improve survival and recovery.
This trial tests if a special fluid given through a vein can protect and repair the lining of your blood vessels during sepsis. Sepsis is a dangerous reaction to an infection that can damage organs. This study aims to see if this treatment helps patients in the intensive care unit (ICU) recover better.
This trial tests new and existing drugs in healthy volunteers to see how they affect the body's response to a substance that mimics sepsis. It helps researchers understand how these drugs might work in people with sepsis.
This trial tests a medication called nafamostat mesilate to help control blood clotting problems caused by severe infections (sepsis). It may be an option for people with sepsis who are at risk of bleeding but do not have active bleeding.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.